BT13 is a molecule that just might be the cure scientists have been looking for to cure Parkinson’s disease.

 

Previous research has shown that people with Parkinson’s disease experience severe loss of cells that produce dopamine. Dopamine is a hormone and acts a chemical messenger  of dopamine producing cells in the brain can lead to Parkinson’s disease.

 

 

BT13: What Is Parkinson’s Disease?

Parkinson’s disease is a progressive, degenerative condition that affects the central nervous system. Symptoms include involuntary limb tremors, rigidity, and slowness of movement.

Currently, around 6.5 million people world-wide suffer from this condition — and at this time, there is no cure.

 

 

Bt13: Potential Cure For Parkinson’s

One of the major problems in finding a cure for Parkinson’s is that many drugs and compounds are unable to cross the blood-brain barrier. The blood-brain barrier a protective border that stops potentially harmful substances and microorganisms from entering the brain. A large number of drugs are unable to cross it.

 

Scientists at the University of Helsinki, Finland, tested BT13 in mice. They found that BT13 increased dopamine in the brains of mice. It also protected the dopamine producing brain  from dying off and, best of all, was able to bypass the blood-brain barrier.

 

Additional animal experiments are necessary and thereafter the scientists must confirm them in human clinical trials. Right now scientists are testing a series of similar BT13 compounds, which were predicted by a computer program to have even better characteristics.

Of course, because the key element, as always, are the human clinical trials. The fact that BT13 can pass the blood-brain barrier is a very exciting development. It actually is the first compound that can pass the barrier to treat this particular disease.